Page last updated: 2024-08-23

silybin and Body Weight

silybin has been researched along with Body Weight in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Cossiga, V; Dallio, M; Di Sarno, R; Federico, A; Gravina, AG; Lama, S; Loguercio, C; Masarone, M; Morisco, F; Persico, M; Stiuso, P; Tuccillo, C1
Ababneh, Q; Alsaggar, M; Alzoubi, KH; Bdour, S; El-Elimat, T; Qinna, N1
Çelik, DA; Özçelik, N; Sevimli, M; Sevimli, TS; Toğay, VA1
Agarwal, R; Chittezhath, M; Deep, G; Raina, K; Rajamanickam, S; Singh, RP1
Felix, AJ; Nalini, N; Sangeetha, N1
Dunnick, JK; Kissling, GE; Nyska, A; Peckham, J; Sanders, JM; Singh, B1
Bosco, P; Di Giacomo, C; Galvano, F; La Delia, F; Li Volti, G; Malaguarnera, M; Marrazzo, G; Nicolosi, A; Scapagnini, G1
La Grange, L; Montoya, R; Moreland, N1
Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD1

Trials

1 trial(s) available for silybin and Body Weight

ArticleYear
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Adult; Aged; Biomarkers; Body Weight; Cytokines; Drug Therapy, Combination; Endothelial Cells; Female; Humans; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Silybin; Vitamin D; Vitamin E

2019

Other Studies

8 other study(ies) available for silybin and Body Weight

ArticleYear
Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice.
    BMC pharmacology & toxicology, 2020, 01-23, Volume: 21, Issue:1

    Topics: Adipocytes; Adipose Tissue; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Body Weight; Diet, High-Fat; Disease Models, Animal; Gene Expression; Glucose; Hypertrophy; Liver; Male; Mice, Inbred C57BL; Obesity; Silybin

2020
DNA damage in rats with streptozotocin-induced diabetes; protective effect of silibinin.
    Mutation research. Genetic toxicology and environmental mutagenesis, 2018, Volume: 825

    Topics: Animals; Body Weight; Case-Control Studies; Comet Assay; Diabetes Mellitus, Experimental; DNA Damage; Male; Rats; Silybin

2018
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Cancer research, 2008, Aug-15, Volume: 68, Issue:16

    Topics: Adenocarcinoma; Animals; Antioxidants; Apoptosis; Biomarkers, Tumor; Blotting, Western; Body Weight; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2008
Silibinin modulates biotransforming microbial enzymes and prevents 1,2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2009, Volume: 18, Issue:5

    Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Bacteria; Body Weight; Colon; Colonic Neoplasms; Disease Models, Animal; Male; Precancerous Conditions; Rats; Rats, Wistar; Silybin; Silymarin

2009
Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle.
    Toxicologic pathology, 2011, Volume: 39, Issue:2

    Topics: Animals; Berberine; Body Weight; Carcinogens; Female; Flavonolignans; Hydrastis; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Plant Preparations; Plant Roots; Rats; Rats, Inbred F344; Silybin; Silybum marianum; Silymarin; Topoisomerase Inhibitors; Toxicity Tests, Chronic

2011
Neuroprotective effect of silibinin in diabetic mice.
    Neuroscience letters, 2011, Oct-31, Volume: 504, Issue:3

    Topics: Animals; Antioxidants; Body Weight; Brain; Brain Chemistry; Diabetes Mellitus, Type 2; DNA Damage; Drug Evaluation, Preclinical; Heme Oxygenase-1; Lipid Peroxidation; Membrane Proteins; Metalloporphyrins; Mice; Mice, Knockout; Mice, Mutant Strains; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Receptors, Leptin; Silybin; Silymarin

2011
Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin.
    BMC complementary and alternative medicine, 2002, Nov-11, Volume: 2

    Topics: Agenesis of Corpus Callosum; Analysis of Variance; Animals; Body Weight; Brain; Corpus Callosum; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Functional Laterality; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Protective Agents; Rats; Rats, Inbred F344; Silybin; Silymarin

2002
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:6

    Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin

2008